Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899140-24-001093
Filing Date
2024-10-22
Accepted
2024-10-22 15:30:53
Documents
2
Period of Report
2024-08-28

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 5044
2 EXPLANATION OF RESPONSES s80184003.htm EX-99.1 3969
  Complete submission text file 0000899140-24-001093.txt   10568
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Issuer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 540 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address
Cowen Aaron (Reporting) CIK: 0001869640 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40560 | Film No.: 241386222